Thank you for your interest in clinical trials for Transitional Cell CarcinomaPlease click "Search" to find Transitional Cell Carcinoma clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned no results. Get alerts when studies become available.
Your search returned 7 studies. (Get alerts for new studies):Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing SurgeryConditions: Recurrent Bladder Cancer - Stage 0 Bladder Cancer - Stage I Bladder Cancer - Stage II Bladder Cancer - Transitional Cell Carcinoma of the Bladder1 Location availableEfficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of SubConditions: Bladder Neoplasm - Intravesical Drug Administration - Neoplasm Recurrence, Local - Transitional Cell, Carcinoma - Carcinoma in Situ - Mycobacterium56 Locations availableFirst-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial CarcinomaConditions: Transitional Cell Carcinoma - Bladder Carcinoma - Urothelial Carcinoma7 Locations availableTesetaxel for Previously Treated Patients With Bladder CancerConditions: Carcinoma, Transitional Cell2 Locations availableA Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerConditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis7 Locations availableDocetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in BladderConditions: Recurrent Bladder Cancer - Stage III Bladder Cancer - Stage IV Bladder Cancer - Transitional Cell Carcinoma of the Bladder1 Location availableBKM120 in Metastatic Transitional Cell Carcinoma of the UrotheliumConditions: Metastatic Transitional Cell Carcinoma of the Urothelium5 Locations available
Didn't find what you were looking for? Try these alternatives: